Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy save search
Regulatory Applications Accepted in the U.S. and Japan for Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma (FL) and Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Published: 2024-01-30 (Crawled : 12:30) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.36%
H: 0.26%
C: -1.32%
breyanzi japan cell
RAYZEBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB
Published: 2024-01-27 (Crawled : 04:20) - prnewswire.com
MSS | $1.22 1.67% -2.5% 23K
|
| Email alert
Add to watchlist
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
| Email alert
Add to watchlist
RYZB | $62.49 0.03% 280K
|
| Email alert
Add to watchlist
alert
Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -1.82%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -0.13%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 1.36%
H: 0.23%
C: -0.76%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.71%
H: 0.48%
C: -0.52%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
report antibacterial sanofi market
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
Published: 2024-01-26 (Crawled : 15:30) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.71%
H: 0.48%
C: -0.52%
chmp positive cell therapy
Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
Published: 2024-01-23 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.928 -1.08% -17.59% 1.9K
|
Health Technology
|
| O: -4.99%
H: 0.0%
C: -0.06%
TRUMY | $16.507 -1.1% 0.79% 34K
|
Manufacturing
|
| O: -1.36%
H: 0.0%
C: -0.82%
WST | $377.33 -0.01% 0.0% 320K
|
Health Technology
|
| O: 0.67%
H: 0.46%
C: -1.49%
TFX | News | $207.38 -0.44% 0.0% 150K
|
Health Technology
|
| O: 0.18%
H: 0.52%
C: -2.57%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.16%
H: 0.84%
C: 0.08%
BSX | $67.42 -0.8% 0.79% 5.9M
|
Health Technology
|
| O: -0.18%
H: 0.5%
C: -0.98%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
PODD | $164.73 -0.92% -0.94% 590K
|
Health Technology
|
| O: 0.07%
H: 1.08%
C: -1.59%
drug global growth market
Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -0.07%
H: 1.38%
C: 1.25%
EVR | $185.29 -0.11% 0.0% 220K
|
Finance
|
| O: 0.35%
H: 0.29%
C: -0.26%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: 0.89%
acquisition
Global Urinary Tract Infection (UTI) Treatment Market is expected to Reach US$ 13,617.4 million by 2034, rising at a 1.9% CAGR- FMI Study
Published: 2024-01-22 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -2.34%
H: 0.43%
C: 0.43%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.76%
H: 0.38%
C: 0.13%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.22%
H: 1.49%
C: 0.89%
expected million reach infection treatment global study market
Bristol Myers Squibb Data at ASCO GU 2024 Showcase Transformative Research in the Treatment of Genitourinary Cancers
Published: 2024-01-17 (Crawled : 14:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.9%
H: 1.05%
C: 0.87%
asco treatment research
Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC
Published: 2024-01-10 (Crawled : 00:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.16%
H: 0.09%
C: -1.05%
ZLAB | News | $14.22 3.64% 3.38% 690K
|
Health Technology
|
| O: 0.38%
H: 1.24%
C: -2.14%
publication advanced
NeuroTrauma Sciences Appoints William Fricker, CPA, MBA, as Chief Financial Officer
Published: 2024-01-09 (Crawled : 13:30) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.5%
H: 0.1%
C: -1.48%
sciences financial
European Medicines Agency Validates Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer and NTRK-Positive Solid Tumors
Published: 2024-01-02 (Crawled : 14:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.27%
H: 3.89%
C: 2.55%
lung tumors cancer cell treatment application advanced
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc.
Published: 2023-12-22 (Crawled : 21:00) - prnewswire.com
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
| Email alert
Add to watchlist
KRTX | $329.83 0.0% 1.9M
|
Health Technology
| Email alert
Add to watchlist
PGTI | $41.99 -0.0% 2.2M
|
Producer Manufacturing
| Email alert
Add to watchlist
AYX | $48.26 0.0% 6.8M
|
Technology Services
| Email alert
Add to watchlist
PGTI | $41.99 -0.0% 2.2M
|
Producer Manufacturing
| Email alert
Add to watchlist
acquisition
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
Published: 2023-12-22 (Crawled : 20:00) - biospace.com/
PTCHF | $2.78 19.97% 560
|
n/a
|
| O: 29.67%
H: 0.0%
C: -5.76%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 47.74%
H: 0.0%
C: 0.0%
therapeutics acquired
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -2.93%
NVO | $122.75 -1.43% 0.65% 2.7M
|
Health Technology
|
| O: -0.31%
H: 0.39%
C: -0.44%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.18%
H: 0.5%
C: -0.46%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
REGN | $893.99 -0.8% -0.84% 450K
|
Health Technology
|
| O: 0.52%
H: 0.58%
C: 0.05%
GILD | News | $66.16 -1.15% -1.16% 4.9M
|
Health Technology
|
| O: 0.34%
H: 1.02%
C: 0.59%
BIIB | $190.52 -0.85% -0.84% 1.3M
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.04%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.06%
H: 0.18%
C: -1.06%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.24%
H: 2.03%
C: 1.49%
patent report global market
Bristol Myers Squibb to Present at J.P. Morgan’s 42nd Annual Healthcare Conference
Published: 2023-12-22 (Crawled : 13:30) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
conference
Antipsychotic Drugs Market Forecasts 2023-2028 - Market Set for Growth, Forecasted at CAGR of 5.94% from 2023 to 2028
Published: 2023-12-15 (Crawled : 23:00) - prnewswire.com
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
| Email alert
Add to watchlist
set market
Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024
Published: 2023-12-15 (Crawled : 22:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.6%
H: 0.57%
C: -0.53%
report results
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
Published: 2023-12-14 (Crawled : 12:00) - prnewswire.com
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 1.16%
H: 0.14%
C: -1.89%
collaboration therapeutics
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -1.67%
H: 1.17%
C: 0.85%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 1.16%
H: 0.14%
C: -1.89%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
cancer global immunotherapy market
Two Early Studies Evaluating Potential First-in-Class CELMoD™ Agent Golcadomide for the Treatment of Non-Hodgkin Lymphomas Presented at ASH 2023
Published: 2023-12-12 (Crawled : 08:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.57%
H: 0.28%
C: -0.57%
treatment lymphomas potential
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.